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FROM the fact that certain mouse tumours could be transplanted using freeze-
dried tumour tissue, Gye, Begg, Mann and Craigie (1949) concluded that they had
evidence of virus transmission of their tumours. Subsequently, it was shown
(Passey, Dmochowski, Lasnitzki and Milard, 1950) that a small proportion of the
cells in these tumours were able to withstand freeze-drying as indicated by the
proliferation in vitro of tumour tissue so treated. These findings focused atten-
tion on the quantitative aspects of tumour transplantation, and various observa-
tions were made which suggested that the malignant cell population in sarcoma-
tous ascitic fluids is heterogeneous. Craigie, Lind, Hayward and Begg, (1951)
reported that a small proportion of the sarcoma cells in certain ascites tumours
could be distinguished from the modal cells by their peculiar appearance under
phase-contrast microscopy, and by their relative resistance to freezing and to
the inimical effects of exposure to isotonic glucose. Lasnitzki (1952) showed
that a high proportion ofthe cells of Sarcoma 37 (hereafter referred to as " S37 ")
ascitic fluid undergo morphological transformation in tissue-culture and do not
subsequently divide; she found that this change was accompanied by a reduction
in the power ofthe cells to give rise to a tumour ontransplantation, and considered
her observations to be evidence of bimorphism of the S37 cells.
Histological studies of the fate of implants of tumour tissue have not given
conclusive evidence that the cells of the new tumour are direct descendants of the
cells intheimplant. Gye etal. (1949) stated thattheappearance ofimplants which
had been frozen previous to inoculation, although they subsequently would give
rise to tumours, " did not suggest survival of any ofthe implanted tissue." Zahl
and Drasher (1947) drew similar conclusions from their observations of the fate of
implants of Sarcoma 180 in mice. These authors state that there is no increase
in the size oftheimplant andthat it undergoes immediate cytological degeneration.
Several previous workers have studied the variation of tumour incidence with
the number of cells inoculated. De Gaetani and Blothner (1936) found that over
100,000 cells were generally required for the successful transplantation of mouse
carcinoma and sarcoma. Furth and Kahn (1937), working with an inbred strain
of mouse and a spontaneous leukaemia derived from that strain succeeded in
transplanting leukaemia to about 5 per cent of their mice by the intravenous
inoculation of a single leukamic cellW Kahn and Furth (1938), using the trypanH. B. HEWITT
blue and neutral red reactions to distinguish viable from non-viable cells, obtained
tumours from about 20 per cent of subcutaneous sites inoculated with 50-100
viable sarcoma cells.
In the present paper a comparative study is reported of the quantitative
transplantation of S37 in mice displaying evidence of resistance to it, and of a,
C3H sarcoma in C3H mice giving conditions in which resistance phenomena are
presumed to be absent.
In circumstances where there is a genetic difference between the animal in
which a tumour arose and those to which it is transplanted, the behaviour of the
tumourisusuallymodifiedbytheresistance ofthehost. It hasbeen oftenasserted
that the studyoftransplantable tumoursunderthese conditions has littlerelevance
toinducedandspontaneous carcinogenesis, wheretheresultingtumoursarederived
from the hosts' own cells. There is considerable evidence however, that resis-
tance phenomena are in fact displayed by animals against tumours which have
beeninducedinthem. Virusinducedpapillomas ofthe domesticrabbitfrequently
undergo regression, as do also the early rabbit papillomas induced by coal tar
(Rous and Kidd, 1941). Studies of the co-carcinogenic effect of croton oil have
suggested that tumour cells induced in mouse skin by 9: 10-dimethyl-1: 2-benzan-
thracene remain latentfor many months, only developinginto franktumours under
the action ofthe co-carcinogen (Berenblum and Shubik, 1949). Andervont (1936)
found that systemic treatment with trypan blue increased the incidence and
reduced the latent period ofsarcoma production in mice by a chemical carcinogen.
This last finding is of special interest in this connection because trypan blue, as is
well known, depresses the resistance mechanisms which are manifest in strain
heterologous transplantations. Strong (1948) has shown that the Fl progeny
ofa cross between twoinbred strains (NHO andC57) exhibit aresistance to tumour
production by methylcholanthrene which varies with litter seriation. Since the
Fl mice are genetically identical, he concluded that this resistance must be attri-
buted to a factor which is transmitted from the mother to her litters by a non-
genetic route and which varies in potency with the age of the mother.
These variouspieces ofevidence are consistent with a hypothesis that progressi-
vely growing tumours, whether spontaneous or induced may arise from a selected
fraction ofalargerpopulation ofpotentiallymalignant cells; failure oftheremain-
ing cells to proliferate into tumours could be due to their having been brought
under control of the resistance mechanisms of the host at a time when they were
present in small numbers. If this hypothesis is true, the induction of tumours
might be facilitated by non-carcinogenic influences which act by depressing the
resistance mechanisms of the host.
It is clearfromthe workofFurth andKahn (1937) ontransplantable leukaemia
that even where there is no reason to suspect a genetic difference between the
tumour cell and the inoculated host, any single viable tumour cell stands only a
small chance of giving rise to a tumour on transplantation. This suggests either
that only a small fraction of the tumour cells have the power of proliferation,
or that every cell with such power is subjected to considerable hazards in the
process of being transplanted.
The experiments described in this paper, suggested by the considerations
which have been discussed, were undertaken as part of a study of some local and
systemic factors which may influence the fate of inocula of small numbers of
malignant cells.
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MATERIALS AND METHODS.
Tumours.
(1) S37 was maintained by serial passage in stock albino mice either as solid
tumours or as ascitic tumours.
(2) A spontaneous C3H sarcoma which arose in a transplantable mammary
carcinomaofthesame strain. Thesarcoma wasmaintained byserialsubcutaneous
passage in C3H mice.
Mice.
Transplantable experiments with S37 were all performed using stock albino
mice bred in this laboratory. These mice were not pure line but were all derived
from an original colony of 20 mice.
All experiments with C3H Sarcoma were performed using C3H mice bred in
this laboratory by sib mating.
Preparation ofsingle-cell suspensions.
Single-cell suspensions of solid tumours wereprepared as follows: one or more
subcutaneous tumourswerefinelymincedwith scissorsafterremoval ofall adherent
subcutaneous tissue; the mince was made into a 10-20 per cent suspension in a
0*5 per cent solution of gelatine in Tyrode solution, this medium being adjusted
to pH 7*2-7-4 and sterilised by Seitz filtration; the suspension, in a 50 ml. cylinder
was allowed to stand at room temperature for 10 minutes, after which the middle
one-third was removed through a fine pasteur pipette to several 10 mm. x 75 mm.
glass tubes; these tubes, each filled to a level 6 cm. above the base were allowed
to stand in a strictly vertical postion for 75 minutes at 3-5° C.; the upper 2 cm.
of each column was then removed slowly through a fine pipette, care being taken
to see that the point of the pipette was kept near the surface of the fluid being
extracted; the upper 2-cm. fractions from several tubes were pooled. 20-c.mm.
volumes of suspensions prepared in this way were usually found to consist almost
exclusively ofsingle cells, there being only very occasional aggregates of 2-6 cells.
Suspensions failing to attain this standard were not used for titrations.
S37 ascitic tumour suspensions were used without prelinminary sedimentation
iffound to be free from cell clumps. When clumps were present a 10-fold dilution
of the ascitic fluid was subjected to the second phase of the sedimentation
procedure described above for solid tumour preparations.
It should be mentioned here that parallel titrations of a suspension diluted
(a) in the gelatine-Tyrode medium described, (b) in a 2-fold dilution of cell free
mouse ascitic fluid in Tyrode solution, gave results which were found to be not
significantlydifferent whenexamined bystatisticalteststobedescribed. Further-
more, successful transplantation of S37 cells into new-born mice has been secured
with malignant ascitic fluid which has been diluted nmore than a million times in
the artificial medium (Hewitt, 1953). It has been concluded from this evidence
that use of the artificial medium has not introducted factors which seriously
influence the results to be described.
Cell counts.
Between 30 and 94 per cent of the single cells in suspensions prepared from
solid tumours exhibited nuclear staining in the presence of trypan blue or eosin,
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a reaction usually regarded as being incompatible with cell viability (Schrek,
1936b; Pappenheimer, 1917). Counts ofsuspensions preparedfrom solid tumours
were tberefore made after mixing equal volumes of the suspension and 0 5 per
cent trypan blue (B.D.H., biologically tested) in M/15 Sorensen buffer at pH 7-2.
No ascitic cellsuspension has beenfound to contain more than 3 per cent ofstained
cells, and counts of these suspensions were made in the absence of trypan blue.
Trypanbluewaspreferredtoeosinforthedifferentiation ofnon-viablecellsbecause
it gave more definite staining at non-toxic levels. Counts were made in a Fuchs-
Rosenthal haemocytometer using phase-contrast microscopy.
The absence of any reliable morphological criterion by which to identity a
viable tumour cell makes it impossible to signify with certainty whether a given
cell is a malignant cell or a normal cell contributed by the cellular reaction ofthe
host. It has been found convenient to make an arbitrary distinction between
normaltissue cellsandsarcoma cellsinfreshsingle-cellpreparations ofthetumours
used in this study, on the basis of cell diameter. It was noted that 90 per cent
ofthe nucleated single cells in sedimented preparations ofminces ofnormal mouse
lymph gland, thymus and spleen, and 70 per cent of the cells in saline washings
of normal mouse peritoneum had diameters of 9,t or less. On the other hand, a
relativelysmallproportion (10-20 per cent) ofthe cells in manysingle cellprepara-
tions ofthe solid sarcomas or in some S37 ascitic fluids, had diameters ofless than
9,u. The density ofviable cells in a suspension has therefore beentakenas equiva-
lent to the density of cells having a diameter of over 9,t and failing to stain with
trypan blue. After considerable experience had been gained ofthe measurement
of the cells in fresh preparations, actual measurement of the cells was abandoned
and the larger cells were selectively counted by estimation of their size. Fre-
quency distribution curves ofthe diameters ofthe single cells ofsarcoma prepara-
tions showed a modal diameter in the region 14-16,t. A smaller, second peak
was sometimes seen at about 7,u, and this was considered to represent the mode of
the inflammnatory cell population in the suspension. The effect of elimination
from the cell count of all cells of diameter less than 9,u was to exclude from the
count the great majority of the non-tumour cells. On the other hand, a count
oftumour cells made using this criterion might represent only 80 per cent, but no
less, of the actual number of tumour cells present.
Titration ofsarcoma cell suspensions.
If necessary, the counted S37 cell suspensions were diluted to contain about
20,000 tumour cells in 0Q1 ln. (the inoculum volume). Of this suspension, five
3-fold dilutions were made in the gelatine-Tyrode medium, giving a series of six
suspensions with cell densities varying from about 20,000/0 1 ml. in the lowest to
about 80/0 1 ml. in the highest dilution. The coresponding range suitable for
the titration of the C3H sarcoma in C3H mice was from about 200 cells/0 1 ml.
to about 0-8 cells/0.1 ml. 041 ml. volumes of each dilution were inoculated sub-
cutaneously into a group usually of 4-6 mice. Each mouse of a group received 4
inoculations of the appropriate dilution, one in each axilla and one in each groin.
When the fate of small inocula in treated mice was to be compared with their
fate in controls, a suspension was titrated simultaneously in two series of mice
each consisting of 6 groups of 4-6 mice. The distribution of mice between the
treated and control series was such that each mouse ofa group in one series was a
370QUANTITATIVE TRANSPLANTATION OF MOUSE SARCOMA
litter mate ofa mouse in the corresponding group ofthe other series Mice ofthe
two series were inoculated alternately. The inoculations were made using a
10 ml. tuberculin syringe carrying a No. 12 needle. To facilitate accurate placing
of the inocula, all inoculations were given under ether anaesthesia. Throughout
allmanipulations from the time ofsetting up the second phase ofthe sedimentation
procedure until inoculation, the suspensions were kept at 2-5° C. Full aseptic
technique was employed throughout and special precautions were taken to keep
the suspended celis in homogeneous distribution.
Recording oftumour incidence and calculation of end-points.
Inoculated mice were examined for palpable tumours at 2-3 day intervals
from the 6th till the 30th day after inoculation in the case of S37 and from the
6th to the 40th day after inoculation in the case of the C3H sarcoma. It was
found that, withveryfewexceptions, the smallest detectable mass in an inoculated
sitewouldbecome a definitetumourwithinafewdays ofitspresentation. Regres-
sion occurred in a fairly high proportion of the S37 tumours derived from the
smaller inocula, but was unusual except in tumours which had attained moderate
size. Once a tumour had been recorded for any site, the subsequent behaviour
ofthe tumour did not affect the record. The result ofeach inoculation was there-
fore recorded in the form ofa quantal response. The proportion ofsites in which
a palpable tumour formed was recorded for each of the 6 different tumour cell
doses inoculated. In an ideal titration, all sites inoculated with the highest dose
of cells gave tumours and all those inoculated with the lowest dose failed to give
tumours. From these data, the number oftumour cells which would have given
tumours in 50 per cent of the inoculated sites (hereafter referred to as " TD50 ")
was calculated by the method of Reed and Muench (1938). The computing of
the results by this method ensured that the data from all sites were used in the
calculation ofthe TD50.
EXPERIMENTS AND RESULTS.
1. Variation in TD50 values obtained in (i) separate titrations of different S37 cell
suspensions and (ii) parallel titrations qf the same suspension.
In 16 titrations of different S37 cell suspensions performed in the manner
described and using 4-6 mice per group, the TD50 values ranged from 603 to 3162
cells, with a mean of 1641 and a coefficient ofvariation of 51 per cent. The ratio
ofthe highest to the lowest value obtained in this series was 5-2.
It has not been possible to correlate this variability with any one factor known
to vary from one experiment to another. Suspensions prepared from tumours
during their early growth phase and those prepared from older tumours gave
results which were not consistently different. It is clear, however, that the varia-
bility in results from one experiment to another is contributed to both by unspeci-
fied differences between the suspensions and by random differences in the batches
of mice used for the titrations. In order to assess the order of variability in
results which may be expected in parallel titrations of the same suspension, a
number of paired titrations were performed using 2 series each of 6 groups of 2-3
mice. In these experiments the mice were of comparable age but the members
of corresponding groups were not litter mates. The ratio of the TD50 values
obtained for 8 such pairs of titrations ranged from 1-0 to 1-82. The mean ratio
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was 1*27 and the standard deviation from 1.0, calculated through the logarithms
of the ratios, was 0 4. The values 2 SD and 3SD corresponded to ratios respec-
tively of 2-0 and 2-82, so that a significant difference between the TD50s obtained
for parallel titrations in control and treated animals should be considered when
their ratio exceeds 2-0. This figure was used as a guide; the following further
test of significance being applied when the ratio of the results exceeded 2-0: the
TD50 and its standard error were calculated from the results of each titration
by the approximate method of Irwin and Cheeseman (1939); the limits of error
ofeach TD50 were defined from a value 3 x S.E., and a significant difference was
inferred when the limits oferror ofthe TD50with the greatest S.E. did not include
the TD50 value given by the other titration. This criterion of significance was
used by the authors of the method to compare LD50s in certain toxicity tests.
The adequacy of the test in the present context appears to be justified by the
following considerations: the multiple difference of TD50 values obtained in
8 pairs oftitrations using only 2-3 mice per group, and with only random pairing
of mice between the two series, did not exceed 2*0; in the parallel titrations to
the results ofwhich the test was applied, however, there were 4-6 mice per group,
and each mouse of one series was carefully paired with a mouse in the correspon-
ding group of the other series, the members of a pair being usually litter mates
but occasionally mice from two litters born on the same day. The multiple
difference required to achieve significance by the test was about 4 0.
2. Variation in the ability ofdifferent sites to grow tumoursfrom small inocula.
In the course of examining large numbers of mice each of which had received
four equal subcutaneous inocula of S37 tumour cells, it has been observed that
tumours growing from inocula in the axillary region usually have a distinctly
higher growth rate than those growing in the groin region. This finding would
seem to indicate that there issome differencebetweenthe tumourbeds inthese two
situations. It was consideredtobe ofsomeinterest toknowwhethersmallinocula
in the axillary sites gave a higher incidence of tumours than equivalent inocula
in the groin sites.
Micegivingonly 1 or 2 tumours from 4equivalentinoculated sites areevidently
those in which site differences were a critical factor in the determination oftumour
incidence. The incidences in the various sites of 294 tujours which arose in 208
mice that had developed only 1 or 2 tumours from equal inocula in the 4 standard
subcutaneous sites are given in Table I.
TABLE I.-Comparitive incidence ofS37 Tumours in Different
Subcutaneous Sites ofInoculation.
Number of
sites Number of
Site. inoculated. tumours. Percentage.
R. axilla 208 . 95 . 45-7m R. groin 208 . 55 . 26-4Jmean, 360
L. axilla . 208 . 72 . 34 6m L. groin . 208 . 72 34.6Jmean, 346
The incidences in the various sites were examined for significant differences
by calculating a value for X2 from four-square tables. The incidence in the right
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axilla is significantly higher than that in the right groin (p =<0.001); this.
results in a significantly higher combined incidence in the axillae compared with
the groins (p <001). There is no significant difference between the incidences
on the two sides when the total incidence oftumours on the right side is compared
with that on the left. It is considered that the difference of incidence between
the two axillae and between the two groins is attributable to some technical incon-
sistency peculiar to the inoculator rather than to an intrinsic difference between
the corresponding sites on the two sides. The differences could result, for example
from a consistent difference in the various sites of the angulation or depth of
penetration of the inoculating needle. Technical variations of this kind could
vary the chance, from site to site, of muscle being entered. Inocula into muscle,
as will be seen below, give a higher yield of tumours than equal inocula into the
subcutaneous tissue. These observations show the importance of practising site
rotation when the fates of two different inocula are to be compared in
the same animal.
The fact that both axillary tumours are usually larger than the groin tumours,
2-3 weeks after equal inoculations in these sites is evidently not correlated with a
difference of incidence in these two regions, as shown by the identical incidences
in the left axilla and groin.
Small inocula of S37 cells in muscle gave a significantly higher incidence of
tumours than equal inocula in the subcutaneous tissue. A S37 ascitic cell suspen-
sion was titrated in 6 groups of 10-12 mice each. Each mouse received four
equal inocula in the following sites: subcutaneously in the right axilla and right
groin; intramuscularly in the medial muscles of the proximal segment of the
left forelimb and in the adductor muscles ofthe left leg. The TD50 for the intra-
muscular sites was 245, compared with 1288 for the subcutaneous sites. This
5-fold difference was found to be significant.
3. The inter-actions of multiple inocula in a single mouse.
No normal mouse of the age and stock used has failed to develop a palpable
tumour from the inoculation of undiluted S37 mince or of single-cell suspensions
of over 100,000 viable cells. Nevertheless, the behaviour of S37 transplants in
the mice used displays the immunological phenomena characteristic of most
strain-heterologus transplantations: regression occurs in a high percentage of
tumours, and solid immunity to a second transplant usually follows upon the
regression. From the fact that growth of S37 in the mice used results in the
induction of resistance it must be assumed that each of several simultaneous
inoculations into the same animal, whether of equal or of graduated doses, may
be subject to influences of a constitutional nature induced by the others.
To investigate this possibility a suspension of S37 cells was titrated in two
series ofmice. Each series consisted of6groups of5 mice each, and corresponding
groups ofthe two series received the same dilution ofthe suspension and the same
cell dose per inoculum. Each mouse of a group in one series (S) received a single
inoculum of the appropriate dilution subcutaneously in the right axilla. Each
mouse ofa group in the other series (M) received 6 subcutaneous inocula, all ofthe
same size, one ofthese being in the right axilla. When the TD50s were calculated
from the right axilla results alone for each series their ratio was 1-6, the difference
being not significant It was concluded that the practice of giving four equal
inoculations per mouse, in order to increase the number ofsites used in the calcula-
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tions, was probably not associated with results peculiar to the multiple inoculation
procedure itself provided that the several inocula in each mouse were of equal
sizes.
A further experiment was designed to show whether the resistance induced
by a large inoculum was capable ofpreventing a smaller inoculum ofcells, placed
simultaneously elsewhere in the same animal, from becoming a palpable tumour.
A number of 3-5-week-old albino mice were randomised to give one series (C) of
6 groups of5 mice each and a second series (M) of20 mice. A series of6 three-fold
dilutions of a counted S37 cell suspension was prepared. The dilutions were
inoculated into the mice ofthe successive groups ofthe C series in the usual way,
4equalinocula being given to each mouse subcutaneously in the groin and axillary
sites. Each mouse ofthe M series received one inoculum ofeach ofthe 6 dilutions
in separate subcutaneous sites. In the M series, therefore, each mouse carried
one inoculum ofall the dilutions so that each ofthe five smallest inocula was asso-
ciated in the same animal with a larger inoculum inoculated simultaneously else-
where. In each series there were 20 sites inoculated with each dilution of
the suspension.
TABLE II.-Results of Titrations under Conditions where (S) Each
Mouse received 4 Inocula of a Dilution, (M) Each Mouse
received 1 Inoculum ofEach Dilution.
Cells/inoculum . . . . . 20,000 . 6667 . 2222 . 741 . 247 . 82
F Per cent sites giving tumour . 100 . 95 . 75 . 45 . 15 . 30
S'series Mean latent period (days) . 6 2 . 8 7 . 130 . 14- 7 . 14 7 . 182 ICells/anial4 4 4 4 4 4 l Cells/inoculum * * * 4. 4 . 4 * 4 * 4 * 4
F Per cent sites giving tumour . 95 . 90 . 75 . 50 . 15 . 0
M series Mean latent period (days) . 6-2 . 7-2 . 8-3 . 143 . 19 0
{ Cells/animal
Cells/inoculum * * * 2 . 4 . 13 . 40 . 121 . 365
In Table II are recorded for each cell dose in each series of mice: the percen-
tage of inoculated sites developing palpable tumours, the mean latent period
elapsing between the time of inoculation and the time when the tumours were
first palpated, and the multiple by which the number of cells in the inoculum is
exceeded by the total cells inoculated into the animal. The mean latent periods
ofall tumours arising from inocula of 247, 741 and 2222 cells (i.e., in the region
of the TD50) in the S series and in the M series were respectively 13-7 days and
11-4 days. The 30 per cent incidence of tumours from 82 cells in the S series
is fortuitously high, as may be seen from the trend of inoidence in this series.
It is clear that the relatively high total inocula per animal with whichthe 247, 741
and 2222 cell inocula were associated in the M series (see last horizontal column
ofTable II) has not significantly diminished the incidence or extended the latent
periods of the tumours produced by these inocula. The TD50s calculated forthe
S and M series were respectively 708 and 955. Their ratio, 1-3, shows that they
are not significantly different.
A useful conclusion which can be made from the results of this experiment is
that the performance of parallel titrations of two different suspensions in a single
series of mice, corresponding dilutions of the two suspensions being inoculated in
opposite sides ofthe mice, is unlikely to result in suppression ofthe inocula ofthe
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less potent suspension by those ofthe greater, provided that the expected multiple
difference is not large.
4. The effect of " Hyalase " of the tumour incidence from small inocula of S37 cells.
A single-cell suspension ofS37 was titrated in two parallel series ofmice. The
dilutions used to inoculate corresponding groups of the two series were identical
in volume and cell density, but each inoculum given to one series contained 5
Benger Units of " Hyalase " (Benger), whereas the inocula given to the control
series were free from " Hyalase." The TD50s in the control and " Hyalase"
series were respectively 2512 and 2630 (ratio, 1.05).
Whentrypanblue stainability wasused as aviablity test, there was no decrease
in the proportion of viable cells after 2 hours' contact at 370 C. with the same
concentration of " Hyalase " as used above. Thus, since " Hyalase " does not
appear to damage the viable cells, it can be concluded that the presence of
" Hyalase " in the concentration used did not enhance the ability of a small
inoculum to form a palpable tumour.
5. The influence of dead S37 cells upon thefate of small inocula ofviable cells.
In the following two experiments the effect of dead tumour tissue upon the
fate ofminimalinocula S37 cells has been studied under two conditions: (i) where
the dead tissue was inoculated intraperitoneally previous to the inoculation of
viable tumourcellssubcutaneously, and (ii) where thedeadtissuewasincorporated
in the inocula ofviable cells.
A S37 single-cell suspension was titrated in a control series of mice and in a
parallel series each mouse of which had been inoculated intraperitoneally with
0 5 ml. of 20 per cent S37 mince freshly killed by repeated freezing and thawing.
The inoculation with dead tumour tissue was made 48 hours before titration of
the viable cell suspension. No significant difference between the TD50s was
obtained in the two titrations, their ratio being 1-07.
The second experiment was designed to show whether tumour production
from minimal inocula is depressed or enhanced by the presence in the inoculum
of a large preponderance of dead cells. A single cell suspension of S37 cells was
prepared from a subcutaneous tumour by the usual method and the density of
viable cells was determined. Two series of 5 three-fold dilutions were prepared
fromthis, theseparateseriesbeingmaderespectivelyinthe twofollowingdiluents:
A. 0 5 per cent gelatine in Tyrode solution.
B. A suspension in 0*5 per cent gelatine in Tyrode of single S37 cells
freshly killed by repeated freezing and thawing. This suspension, con-
taining over 106 trypan blue stainable cells per inoculum volume (0.1 ml.),
failed to give rise to any tumours when inoculated into 10 normal
young mice.
The ratio of dead to live cells in all the dilutions in Diluent A was 3: 2. In
Diluent B theratio rosefrom 3 : 2inthelowestdilution to 10,000: 1 in thehighest.
Thus in the last series, the smaller the viable cell concentration, the higher the
proportion of dead cells with which they were associated.
The different dilutions of each series were inoculated subcutaneously into
separate groups ofmice, each mouse receiving 4 inoculations.
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The TD50 values obtained in the two series were as follows:
Dilutions in gelatine-tyrode diluent . . . 2818
Dilutions in dead cell suspension . . . . 661
Although the difference (ratio 4.3) was considerable, it did not quite attain
significance by the Irwin and Cheeseman (1939) test. The conclusion made is
that a high proportion of dead cells in small inocula of viable S37 cells does not
significantly inhibit, but may enhance, the development of tumours from the
.inocula.
6. Comparison of transplantability of S37 cells derivedfrom malignant asciticfluid
andfrom solid tumour.
The most striking differences between the single-cell populations of malignant
.ascitic fluid and those of suspensions prepared from solid subcutaneous tumours
-are differences in the relative proportions of (a) inflammatory cells, (b) presumed
viable tumour cells (failing to stain with trypan blue), and (c) presumed non-
viable cells (exhibiting nuclear staining with trypan blue). Comparable titrations
of single-cell suspensions prepared from these two different sources provide a
-useful means of comparing the tumour-producing activities of these various
cell types.
Eight separate titrations of S37 cell suspensions prepared from solid tumours
gave a mean TD50 of 2018 ± 369 (18-2 per cent). Eight separate titrations of
suspensions prepared from malignant ascitic fluid gave a mean TD50 of 1264 ±
158 (12.5 per cent). The difference of these means is not significant though a
tendency of the viable ascitic tumour cells to be more active on transplantation
-was suggested by the results. An experiment was therefore designed to compare
under more carefully controlled conditions the activities on transplantation oftwo
suspensions prepared respectively from these two sources.
Malignant ascitic fluid and four moderate sized subcutaneous tumours of S37
-were harvested from a single mouse inoculated intraperitoneally and subcutane-
ously with S37 mince 15 days previously. A single-cell suspension was prepared
from the solid tumours in the usual way; the diluted ascitic fluid was subjected to
the same sedimentation procedureasthe solidtumour mince toensurethat anycell
size selection involved in the sedimentation should be the same for both suspen-
sions. In counting the cells in each suspension a distinction was made between
three types ofcellwithinthetotal cellpopulation: cells not stainedby trypanblue
and over 9,u in diameter (presumed to be mostly viable tumour cells), cells not
stained by trypan blue and 9,u or under in diameter (presumed to be mostly
-inflammatory cells), and cells stainingwithtrypan blue (presumed to be non-viable
tumour cells).
The ascitic cell suspension was diluted to contain the same number of large
viable cells as in the solid tumour preparation. Although there were then equal
,densities of large viable cells in the two suspensions, the densities of the other
-types of cell in the two suspensions were unequal. Table III shows the relative
-densities of each type of cell in the two suspensions.
Of each of the starting suspensions, containing equal numbers of presumed
viable tumour cells, 5 three-fold dilutions were made in the gelatine-Tyrode
-medium and parallel titrations of the tow suspensions were done in two separate
:series of mice. In Table IV are recorded the TD50 values calculated separately
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for each type of cell in the two suspensions. The ratio of the TD50s given by
the two suspensions also is given for each type of cell.
TABLE III.-Relative Densities* of Cell Types in Suspensions
preparedfrom (a) Ascitic Fluid, (b) Solid Tumours, ofS37.
Ascitic fluid Solid tumour
Cell type.t suspension. suspension.
A . . 1 . . 1
B . . 1 . 2
C . . 1 . . 93
* The ratios shown apply only within each horizontal column.
t Key to cell types:
A. Cells over 9pand unstained with trypan blue.
B. Cells 9 p or under and unstained with trypan blue.
C. Cells stained with trypan blue.
TABLE IV.-TD50 Values given by Cell Typefor Suspensions preparedfrom
(a) Ascitic Fluid, (b) Solid Tumour S37.
TD50 TD50 Ratio of
Cell type.* ascitic fluid. solid tumour. TD50s.
A . 1698 . 3,548 . 2-1
B . 339 . 1,413 . 4*2
C . 93 . 19,950 . 215
* For key, see Table III.
It will be seen from Table IV that correlation between the TD50 values in the
two seriesishighest when the cell-determining tumourincidence is taken to be the
larger unstained cell. When either the small unstained cell or the stained cell
is taken there is a significant difference between the TD50 values obtairned for
the two suspensions. These findings are in accordance with the assumption that
the cell type securing successful transplantation is a large cell failing to stain
with trypan blue.
When the ascitic cell and the solid tumour cell suspensions were allowed to
stand overnight at 50 C., 20 per cent ofthe large unstained cells in the solid tumour
preparation became stainable with trypan blue, whereas there was no detectable
increase in the proportion if stained cells in the ascitic cell suspension. It can be
inferred from this finding that a relatively high proportion of the unstained cells
in the solid tumour preparation are non-viable-a feature which could account for
the rather greater number ofthese cells required to give TD50 in the solid tumour
cell titration as compared with the ascitic cell titration.
7. Titration ofa C3H sarcoma in C3H mice.
The sarcoma used in these titrations was a spindle cell sarcoma which arose
spontaneously in a transplantable C3H mammary carcinoma after 9 serialpassages
in C3H mice. It closely resembled S37 in its mode or origin, in its histological
appearance, and in the ease with which single-cell suspensions could be prepared
from it. It differed from S37 in the following respects: it failed to produce
ascites tumours on peritoneal inoculation; it regressed earlier and more rapidly
after inoculation into the stock albino mice used for the S37 experiments, but
killed animals ofthe strain of origin.
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A single-cell suspension of this tumour was prepared from a subcutaneous
tumour by the same procedure as was used for the similar preparations of S37
This suspension was titrated in 6 groups of 3-month-old mice, there being 3 mice
per group and 4 inoculations per mouse. The results obtained were strikingly
different from the results oftitrations of S37 in the albino mice. In Table V the
percentages of tumours obtained from cell doses calculated from the dilution
factor are recorded. The TD50 given by the titration was 32.
TABLE V.-Re8ult8 of Titration of C3H Sarcoma in 3-month
old C3H Mice.
Calculated
number of Number of Number Positive
cells in inoculations. of inocula
inoculum. tumours. (per cent).
1200 . 12 . 10 . 83
400 . 12 . 10 . 83
133 . 12 . 10 . 83
44 . 12 . 7 . 58
15 . 12 . 4 . 33
5 . 12 . 4 . 33
TD50 = 32 cells.
Fig. 1 shows the relationship between viable tumour cell dose and the propor-
tion of inoculated sites giving tumours, for the C3H sarcoma and for S37. In
the case ofeach tumour the points shown were obtained from two separate titra-
Average tumour cells per inoculum(loglo)
FIG. 1.-Relationship between number of viable sarcoma cells inoculated into subcutaneous sites
and the proportion of sites giving palpable tumours. S37 and a C3H sarcoma.
0 C3H sarcoma-2 experiments.
S37-2 experiments.
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tions. The accuracy of the points is not sufficient to reveal the true character
of the curves relating cell dose and tumour incidence but it will be seen that the
rate of change of tumours incidence with log. cell dose is roughly similar for the
two tumours. The possible significance ofthis comparison will be discussed later.
When a similar titration of the C3H sarcoma was performed in C3H mice all of
which were over 1 year of age a TD50 of 18 cells was obtained. The older mice
are evidently not less susceptible than the younger. One of the groups in this
titration, each mouse of which received 4 inocula each containing a calculated
number of 3-4 viable cells, yielded a tumour incidence of 50 per cent. Since the
cells were suspended in an inoculum volume of0 I ml., it seems probable that they
were deposited in the tissues at some distance from one another. Ifit is assumed
that there is no mutual influence between the cells under these conditions, it is
reasonable to conclude that tumours can arise from single cells transplanted to
the subcutaneous tissue.
In one titration of the C3H sarcoma two of the four inoculations into each
mouse were made subcutaneously and the other two intramuscularly. Contrary
to what was found in the case ofS37, there was no detectable difference in tumour
incidence between the two tissues.
DISCUSSION.
The variation in TD50 values obtained for titrations of different suspensions
of S37 though wider than that between the values obtained for parallel titrations
of a single suspension, does not necessarily indicate some fundamental difference
in the viable cell populations derived from different tumours. Variation in the
authenticity ofthe viable cell counts, in the batches ofanimals used for the titra-
tions and in the ranges of inoculum size titrated, may account for variation of
the TD50 from one experiment to another. Young, old, and even regressing
tumours have been used indiscriminately for the preparation ofsingle-cell suspen-
sions, and this has not disclosed any association between the activity ofthe viable
cells and the growth state of the tumour from which they were derived. White
and Loeb (1910) have described the successful transplantation of regressing
tumours, and Schrek (1936a) has found no effect of immunity on the growth
capicity of the tumour cells. These findings do not suggest the presence of
humoral factors in regressing tumours which are active against the tumour cells
themselves and encourage the view that regression is the result of primary
breakdown of the stroma.
The significantly lower TD50 values given byintramuscular sites ofinoculation
compared with subcutaneous sites, for S37, might ascribed to the greater vascu-
larity of muscle. On the other hand, this site difference was not demonstrable
for the C3H sarcoma, and a more likely explanation of the site difference found
for S37 would appear to be that local resistance mechanisms are less readily
manifested in the intramuscular sites.
From the results of the experiments recorded in Section 3, it is clear that a
small inoculum of cells is not suppressed, in the period before it forms a palpable
tumour, by multiple and larger inocula ofthe same tumour placed simultaneously
elsewhere in the same animal. This being the case, it seems probable that the
failure to give rise to palpable tumours which is displayed by half the inocula of
about 2000 cells of S37, is not due to induction of systemic immunity by these
26
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inocula themselves during their prepalpable phase of growth. A further observa-
tion which leads to the same conclusion is that in numerous instances one of four
inocula of about 2000 cells into a single animal may give rise to a tumour which
grows progressively for weeks. If the failure ofthe other three inocula to give rise
to tumours had been due to induced systemic immunity in the animal, the single
tumour would not be expected to proceed as though no immunity were present.
The fact that this same tumour may subsequently regress after reaching a quite
considerable size suggests the operation of an induced resistance mechanism which
takes some time to develop. These observations and considerations have led
to the conception that the mechanism which brings about early extinction of the
small inocula before they form palpable tumours is distinct from the induced
mechanism which results in regression of a tumour that has attained moderate size.
The observation that
"Hyalase
"fails to influence the take of small single-cell
inocula or to impose a distinctive form on the resulting tumours is contrary to
what might be expected if some diffusible factor in the inoculum played any
considerable part in the success of the implants.
Craigie (1952) suggested that dead cells or debris may interfere with the acti-
vity of viable tumour cells on transplantation. It is concluded from the results
of the experiments described in Section 5, however, that dead tumour cells do
not interfere with the proliferation of viable cells present in the same inoculum.
A useful inference which may be made in this connection is that a large prepon-
derance of dead cells in an inoculum should not interfere with the detection by
inoculation of a small number of viable cells, these being the conditions met with
when testing the survival oftumour tissue which has been subjected to a damaging
procedure such as freezing.
As explained in Section 6, the observation thatslightly lower TD50 values
were obtained from titrations of suspensions of S37 ascitic cells as compared
with suspensions prepared from solid tumours may be related to the relatively
high proportion of dead (trypan blue stainable) cells which is characteristic of
the latter suspensions. Since dead cells apparently do not interfere with the
proliferation of viable sells (Section 5), and in view of the increase in the number
of stained cells which was observed in suspensions prepared from solid tumours
when they were allowed to stand, it is reasonable to conclude that the solid tumour
preparations contain a relatively high proportion of non-viable cells which fail
to stain with trypan blue. The viable cell counts ofthe solid tumour preparations
therefore tend to be erroneously high. These considerations show that it is not
permissible to conclude from the comparison that there is a difference between
the activities of the viable cells from these two different sources.
The results of the titrations of the C3H sarcoma cells in C3H mice leave little
doubt that single viable cells of this tumour are quite capable of giving rise to
tumours on transplantation to the subcutaneous tissue. This finding emphasises
the necessity for excluding absolutely the possibility of cell contamination in all
experiments designed to provide evidence of non-cellular transmission of tumours.
The ease with which tumours can be derived from inocula of very small numbers
of cells should not be lost sight of when attempts are made to interpret the histo-
-logical changes which occur in small implants of tumour tissue after transplanta-
tion. The necrosis of tumour implants which has been described by several
authors to whom reference has already been made is probably of no significance to
the question of non-cellular transmission of tumours. Indeed the evidence pro-
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vided here shows that tumours which arise in the vicinity of implants of small
fragments oftumour tissue can be derived exclusively from free single cells which
contaminate the surface of the fragment. When single cubes of S37 of 1-2 mm.
,side were dissected from solid tumour and washed individually with Tyrode solu-
tion, an average of over 10,000 viable tumour cells could be recovered from the
separate washings. The appearances of implants of Sarcoma 180 at various
.stages after transplantation, which have been described in considerable detail by
Zahl and Drasher (1947) and which these authors had difficulty in interpreting,
are consistent with the new tumours having arisen from theproliferation of indi-
vidual cells that had been wiped off the surface of the implanted fragments on to
the adjacent tissues of the host during implantation. Necrosis of the main mass
,of the implant could be accounted for by its failure togain intimate contact with
a source of oxygen and nutrients.
In Fig.1 an attempt has been made to compare graphically the relationships
between cell dose (expressed as the logarithm) and tumour frequency for theC3H
sarcoma and for S37. The available mice ofthe strains used did not allow a more
accurate definition of the points relating to the higher and lower tumour frequen-
cies, and thefigure serves to show only that the relationship between cell dose and
-tumour incidence is not greatly dissimilar in the two cases, at least in the region
of the TD50. This suggests that the variability of responsiveness of the sites
is notvery different in the two cases. Ifthis is so, an interpretation of the differ-
ence in the quantitative data relating to the transplantation of the two tumours
centres round the differences in the TD50s. The multiple difference between
these values from thegraph is 27, but the figure will, ofcourse, vary within certain
limits in accordance with variations in theTD50 from oneexperiment to another.
On theoretical grounds it may be assumed that all of theC3H tumour cells
are genetically compatible with their hosts, and that each is capable of giving rise
-to a rumour on transplantation. The comparison of the C3H sarcoma with S37
then suggests that, in the case ofthe latter tumour, only 1 out of 27 (3.7 per cent)
ofthe viable cells are capable ofgiving rise to a tumourin the 4-6-week-old albino
mice. But the incapacity of the majority of the cells to form new tumours on
-transplantation is not due to an intrinsic lack ofproliferative power. Evidence
-reported elsewhere (Hewitt, 1953) shows that when S37 cells are titratedin
new-born albino mice the TD50 levels obtained are no greater than that obtained
for theC3H sarcoma titrated in adultC3H mice. The apparent failure of the
majority of theS37 cells to survive transplantation is evidently attributable to
the genetic difference between the tumour cells and their hosts, this difference
being not manifest in immature mice.
It may be that the ratio1: 27 representsmnerely theaverage number of cells
in the S37 inocula which survives the initial hazards of exposure to the natural
resistance factors in the foreign host, and that those cells which survive do so
fortuitously. The evidence from these studies, however, does not exclude the
possibility that the cells in the inoculum which survive to form a tumour may owe
their survival to an intrinsic peculiarity. Theevidence ofheterogeneity given by
other workers, to which reference was made in the introduction, is notinconsistent
with such a possibility.
Thepossibility thattumours ofunknowngeneticoriginwhich are characterised
bytheircapacity togrow across strain barriers,su-ch as S37 may owe this faculty
to the continuousproduction ofaspectrum ofcells ofvarying gene dependence is
381H. B. HEWITT.
not discounted by genetic studies in which account has been taken only of the
response to massiveinocula. Barrett (1952)hasdescribed a change in thegenetics
of transplantation of a tumour following its growth in a strain foreign to the
strain oforigin. He considered that the change which occurred was not explained
simply by loss of genetic specificity. It is certain that, at one stage during this
change, the cells composing the tumour must have been heterogeneous in respect
of the genetics of their transplantability.
The use of quantitative methods of transplantation in the study of what has
recently been termed " immunogenetics " (Barrett, 1952) invites an experimental
approach to this subject which appears to have received little attention. Such
an approach would require the development of methods of single cell isolation
analogous to those used in bacteriology, followed by comparison of the properties
of tumours derived from such single cells, Mutational changes affecting the gene-
tics of transplantation, growth rate and histological appearance are commonly
observed in transplantable tumours (Snell, 1949). Segregation methods should
greatly increase the scope of such observations.
SUMMARY.
1. Methods are described of preparing single-cell suspensions of mouse sarco-
mata from solid and ascitic tumours, of finding the viable tumour cell density in
thesuspensions, andof" titrating " themfortumourproducingactivityoninocula-
tion. From the results of the titrations a TD50 value (the number of viable
sarcoma cells required to give tumours in halfthe inoculated sites) was calculated
by a standard method.
2. Sixteen titrations of S37 performed in mice ofimpure stock, all members of
which grew the tumour from massive inocula, gave a mean TD50 of 1641 with a
coefficient ofvariation of 51 per cent.
3. The ratio ofthe TD50 values given by paired titrations of a S37 suspension
ranged from 1 0 to 1 82 in 8 different experiments.
4. Intramuscular inocula of S37 cells gave a significantly lower TD50 than
subcutaneous inocula.
5. The tumour-producing activity of cell doses near the TD50 did not appear
to be suppressed by larger inocula placed simultaneously elsewhere in the same
animnal.
6. The TD50 was not modified by the addition of " Hyalase " to the inocula.
7. A large preponderance ofdead cells and debris in the inocula did not reduce,
but may have enhanced the production of tumours from viable cell doses near
the TD50.
8. The TD50 values given by viable S37 cells obtained from solid tumours
were not significantly different from those given by the corresponding cells of
ascitic tumours.
9. The TD50 given by the viable tumour cells of a C3H sarcoma in C3H mice
was about 25. Mice over one year old did not give a value higher than 3-month-
old mice.
10. The significance is discussed ofthe notable difference in TD50 levels given
by S37 in an impure strain of mouse and by the C3H sarcoma in the homologous
mouse strain.
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11. An appreciable incidence of tumours was obtained in C3H mice from cell
doses of under 10 viable sarcoma cells. The implication of this finding for the
problem of cell-free transfer is discussed.
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nical assistance, and to Professor R. J. V. Pulvertaft and Dr. R. J. O'Connor for
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were made.
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